Elsevier

Metabolism

Volume 33, Issue 4, April 1984, Pages 369-374
Metabolism

Altered cell cycle distributions of cultured human lymphoblasts during cytotoxicity related to adenosine deaminase inhibition

https://doi.org/10.1016/0026-0495(84)90201-4Get rights and content

Abstract

Serial-flow cytometric analysis of DNA content of T lymphoblasts (MOLT-4) and B lymphoblasts (MGL-8) was performed to correlate the cytotoxic properties of adenosine deaminase inhibition with alterations of DNA synthesis and disruptions of the cell cycle. The addition of deoxyadenosine up to 50 μmol/L potently decreased the growth of T lymphoblasts, and these changes were enhanced with the addition of 100 μmol/L homocysteine thiolactone. These conditions caused a virtual absence of cells from S and G2M phases after 24 hours. The DNA distribution was similar in cells cultured for 24 hours in 50 μmol/L deoxyguanosine or 2.5 μmol/L hydroxyurea. These observations suggested accumulation of cells in the G1 phase. T lymphoblasts cultured with up to 50 μmol/L adenosine had a substantial decrease in growth, which was not modified by the addition of homocysteine thiolactone. Cell cycle distributions of T lymphoblasts cultured for 24 to 48 hours under these conditions showed mild decreases in the G2M population. The addition of adenosine up to 50 μmol/L decreased the growth of B lymphoblasts, and these changes were enhanced by the addition of 100 μmol/L homocysteine thiolactone. These conditions induced mild decreases in the S-phase population in B lymphoblasts. The addition of deoxyadenosine, even with homocysteine thiolactone, did not modify growth in B lymphoblasts and the cell-cycle distributions were indistinguishable from distributions of control populations after 24 and 48 hours. The observations provide independent support for a reduction of DNA synthesis associated with cytotoxicity during adenosine-deaminase inhibition. These changes were more profound in T lymphoblasts than B lymphoblasts. Cytotoxicity during S and G2M phases and/or a G1S transition block could account for the cell-cycle alterations observed.

References (33)

  • HJ Meuwissen et al.
  • R Hirschhorn

    Clinical delineation of adenosine deaminase deficiency

  • CA Koller et al.

    Treatment of acute lymphoblastic leukemia with 2′-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition

    Cancer Treat Rep

    (1979)
  • RM Paine et al.

    Biochemical consequences of treatment with adenosine deaminase inhibitor 2′-deoxycoformycin

    Adv Exp Med Biol

    (1980)
  • BS Mitchell et al.

    Purinogenic immunodeficiency diseases: Selective toxicity of deoxyribonucleosides for T cells

  • DA Carson et al.

    Differential sensitivity of human leukemic T-cell lines and B-cell lines to growth inhibition by deoxyadenosine

    J Immunol

    (1978)
  • Cited by (3)

    View full text